A critical appraisal of blood-based biomarkers for Alzheimer's disease
Biomarkers that predict the clinical onset of Alzheimer's disease (AD) enable the
identification of individuals in the early, preclinical stages of the disease. Detecting AD at this …
identification of individuals in the early, preclinical stages of the disease. Detecting AD at this …
Alzheimer's disease biomarker utilization at first referral enhances differential diagnostic precision with simultaneous exclusion of Creutzfeldt‐Jakob disease
Z Wang, V Lewis, C Stehmann… - Alzheimer's & …, 2024 - Wiley Online Library
Abstract Most suspected Creutzfeldt‐Jakob disease (CJD) cases are eventually diagnosed
with other disorders. We assessed the utility of investigating Alzheimer's disease (AD) …
with other disorders. We assessed the utility of investigating Alzheimer's disease (AD) …
Plasma brain‐derived tau correlates with cerebral infarct volume
F Gonzalez‐Ortiz, L Holmegaard… - Journal of Internal …, 2024 - Wiley Online Library
Background A blood‐based biomarker that accurately reflects neuronal injury in acute
ischemic stroke could be an easily accessible and cost‐effective complement to clinical and …
ischemic stroke could be an easily accessible and cost‐effective complement to clinical and …
Blood p-tau association with cognitive status and future memory decline in early Alzheimers disease
F Gonzalez-Ortiz, BE Kirsebom, Y Yakoub… - medRxiv, 2024 - medrxiv.org
Importance: Detecting early Alzheimers disease (AD) biological and clinical changes is
crucial for early diagnostic and therapeutic interventions. Objective: To explore the …
crucial for early diagnostic and therapeutic interventions. Objective: To explore the …
Effect of blood collection tube containing protease inhibitors on the pre‐analytical stability of Alzheimer's disease plasma biomarkers
Y Chen, X Zeng, JL Diaz, A Sehrawat… - Journal of …, 2024 - Wiley Online Library
The reliability of plasma biomarkers of Alzheimer's disease (AD) can be compromised by
protease‐induced degradation. This can limit the feasibility of conducting plasma biomarker …
protease‐induced degradation. This can limit the feasibility of conducting plasma biomarker …
Novel diagnostic and prognostic approach for rapidly progressive dementias: Indicators based on amyloid/tau/neurodegeneration (ATN) framework
Y Cheng, SF Chen, YR Zhang, Y Guo… - CNS Neuroscience …, 2024 - Wiley Online Library
Aims Apply established cerebrospinal fluid (CSF) and serum biomarkers and novel
combined indicators based on the amyloid/tau/neurodegeneration (ATN) framework to …
combined indicators based on the amyloid/tau/neurodegeneration (ATN) framework to …
Clinical value of novel blood‐based tau biomarkers in Creutzfeldt–Jakob disease
GM Bentivenga, F Gonzalez‐Ortiz… - Alzheimer's & …, 2024 - Wiley Online Library
BACKGROUND The diagnostic and prognostic performance of the novel fluid biomarkers
brain‐derived tau (BD‐tau) and phospho‐tau217 (p‐tau217) in Creutzfeldt–Jakob disease …
brain‐derived tau (BD‐tau) and phospho‐tau217 (p‐tau217) in Creutzfeldt–Jakob disease …
[PDF][PDF] Blodtest–fönster till hjärnan vid Alzheimers sjukdom
Vi har bevittnat imponerande framsteg inom den kliniska forskningen kring Alzheimers
sjukdom, vilka gett en detaljerad kunskap om den molekylära patologi som karakteriserar …
sjukdom, vilka gett en detaljerad kunskap om den molekylära patologi som karakteriserar …